Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

  1. Nahi, H.
  2. Usmani, S.Z.
  3. Mateos, M.-V.
  4. van de Donk, N.W.C.J.
  5. Oriol, A.
  6. Plesner, T.
  7. Bandyopadhyay, N.
  8. Hellemans, P.
  9. Tromp, B.
  10. Nnane, I.
  11. Zemlickis, D.
  12. Chari, A.
  13. Moreau, P.
Journal:
Leukemia and Lymphoma

ISSN: 1029-2403 1042-8194

Year of publication: 2023

Volume: 64

Issue: 2

Pages: 468-472

Type: Letter

DOI: 10.1080/10428194.2022.2148221 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals